Antibacterial activity of blue light against nosocomial wound pathogens growing planktonically and as mature biofilms

Applied and Environmental Microbiology

Volumn 82, Issue 13, 2016, Pages 4006-4016

  Halstead, Fenella D ^a,b   Thwaite, Joanne E ^c   Burt, Rebecca ^a,b,e   Laws, Thomas R ^c   Raguse, Marina ^d   Moeller, Ralf ^d   Webber, Mark A ^a,b   Oppenheim, Beryl A ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c Biological and Radiological Division   (United Kingdom)

^d GERMAN AEROSPACE CENTER DLR   (Germany)

^e ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOFILMS; ESCHERICHIA COLI; MAMMALS; RADIATION DECONTAMINATION;

ANTI-BACTERIAL ACTIVITY; ANTI-MICROBIAL ACTIVITY; ENTEROCOCCUS FAECIUM; HELICOBACTER PYLORI INFECTIONS; KLEBSIELLA PNEUMONIAE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA;

LIGHT;

ANTIMICROBIAL ACTIVITY; BACTERIOPLANKTON; BACTERIUM; BIOFILM; CELLS AND CELL COMPONENTS; FUNGUS; LIGHT EFFECT; MAMMAL; PATHOGEN; VIABILITY; VISIBLE SPECTRUM; WOUNDING;

ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS); ELIZABETHKINGIA MENINGOSEPTICA; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FUNGI; HELICOBACTER PYLORI; KLEBSIELLA PNEUMONIAE; MAMMALIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA;

BACTERIAL COUNT; BACTERIUM; BIOFILM; CLINICAL TRIAL; DRUG EFFECTS; INJURY; LIGHT; MICROBIAL VIABILITY; MICROBIOLOGY; MULTICENTER STUDY;

BACTERIA; BIOFILMS; COLONY COUNT, MICROBIAL; LIGHT; MICROBIAL VIABILITY; WOUNDS AND INJURIES;

EID: 84976422110     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00756-16     Document Type: Article

References (45)

1. Maclean M, McKenzie K, Anderson JG, Gettinby G, MacGregor SJ. 2014.405 nm light technology for the inactivation of pathogens and its potential role for environmental disinfection and infection control. J Hosp Infect 88:1-11. http://dx.doi.org/10.1016/j.jhin.2014.06.004
2. Mochon AB, Garner OB, Hindler JA, Krogstad P, Ward KW, Lewinski MA, Rasheed JK, Anderson KF, Limbago BM, Humphries RM. 2011. New Delhi metallo-beta-lactamase (NDM-1)-producing Klebsiella pneumoniae: case report and laboratory detection strategies. J Clin Microbiol 49:1667-1670. http://dx.doi.org/10.1128/JCM.00183-11
3. Nordmann P, Poirel L, Toleman MA, Walsh TR. 2011. Does broadspectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J Antimicrob Chemother 66:689-692. http://dx.doi.org/10.1093/jac/dkq520
4. Dai T, Gupta A, Murray CK, Vrahas MS, Tegos GP, Hamblin MR. 2012.Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond? Drug Resist Updat 15:223-236. http://dx.doi.org/10.1016/j.drup.2012.07.001
5. Maclean M, Macgregor SJ, Anderson JG, Woolsey GA, Coia JE, Hamilton K, Taggart I, Watson SB, Thakker B, Gettinby G. 2010. Environmental decontamination of a hospital isolation room using high-intensity narrow-spectrum light. J Hosp Infect 76:247-251. http://dx.doi.org/10.1016/j.jhin.2010.07.010
6. Dancer SJ. 2014. Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination. Clin Microbiol Rev 27:665-690. http://dx.doi.org/10.1128/CMR.00020-14
7. Ashkenazi H, Malik Z, Harth Y, Nitzan Y. 2003. Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunol Med Microbiol 35:17-24. http://dx.doi.org/10.1111/j.1574-695X.2003.tb00644.x
8. Hamblin MR, Hasan T. 2004. Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci 3:436-450. http://dx.doi.org/10.1039/b311900a
9. Maclean M, Macgregor SJ, Anderson JG, Woolsey GA. 2008. The role of oxygen in the visible-light inactivation of Staphylococcus aureus. J Photochem Photobiol B 92:180-184. http://dx.doi.org/10.1016/j.jphotobiol.2008.06.006
10. Goldoni A. 2002. Porphyrins: fascinating molecules with biological significance, p 64-65. In ELETTRA highlights 2001-2002. Sincrotrone Trieste SCpA, Trieste, Italy
11. McDonald R, Macgregor SJ, Anderson JG, Maclean M, Grant MH. 2011.Effect of 405-nm high-intensity narrow-spectrum light on fibroblast-populated collagen lattices: an in vitro model of wound healing. J Biomed Opt 16(4):048003. http://dx.doi.org/10.1117/1.3561903
12. Kleinpenning MM, Smits T, Frunt MH, van Erp PE, van de Kerkhof PC, Gerritsen RM. 2010. Clinical and histological effects of blue light on normal skin. Photodermatol Photoimmunol Photomed 26:16-21. http://dx.doi.org/10.1111/j.1600-0781.2009.00474.x
13. Wainwright M. 1998. Photodynamic antimicrobial chemotherapy. J Antimicrob Chemother 42:13-28. http://dx.doi.org/10.1093/jac/42.1.13
14. Enwemeka CS, Williams D, Hollosi S, Yens D, Enwemeka SK. 2008. Visible 405 nm SLD light photo-destroys methicillin-resistant Staphylococcus aureus (MRSA) in vitro. Lasers Surg Med 40:734-737. http://dx.doi.org/10.1002/lsm.20724
15. Maclean M, MacGregor SJ, Anderson JG, Woolsey G. 2009. Inactivation of bacterial pathogens following exposure to light from a 405-nanometer light-emitting diode array. Appl Environ Microbiol 75:1932-1937. http://dx.doi.org/10.1128/AEM.01892-08
16. Murdoch LE, McKenzie K, Maclean M, Macgregor SJ, Anderson JG. 2013.Lethal effects of high-intensity violet 405-nm light on Saccharomyces cerevisiae, Candida albicans, and on dormant and germinating spores of Aspergillus niger. Fungal Biol 117(7-8):519-527
17. Murdoch LE, Maclean M, Endarko E, MacGregor SJ, Anderson JG. 2012.Bactericidal effects of 405 nm light exposure demonstrated by inactivation of Escherichia, Salmonella, Shigella, Listeria, and Mycobacterium species in liquid suspensions and on exposed surfaces. ScientificWorld-Journal 2012:137805
18. Maclean M, Murdoch LE, MacGregor SJ, Anderson JG. 2013. Sporicidal effects of high-intensity 405 nm Visible Light on endospore-forming bacteria. Photochem Photobiol 89:120-126. http://dx.doi.org/10.1111/j.1751-1097.2012.01202.x
19. Kawada A, Aragane Y, Kameyama H, Sangen Y, Tezuka T. 2002. Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in vitro investigation. J Dermatological Sci 30:129-135. http://dx.doi.org/10.1016/S0923-1811(02)00068-3
20. Noborio R, Nishida E, Kurokawa M, Morita A. 2007. A new targeted blue light phototherapy for the treatment of acne. Photodermatol Photoimmunol Photomed 23:32-34. http://dx.doi.org/10.1111/j.1600-0781.2007.00268.x
21. Ganz RA, Viveiros J, Ahmad A, Ahmadi A, Khalil A, TolkoffMJ, Nishioka NS, Hamblin MR. 2005. Helicobacter pylori in patients can be killed by visible light. Lasers Surg Med 36:260-265. http://dx.doi.org/10.1002/lsm.20161
22. Yin R, Dai T, Avci P, Jorge AE, de Melo WC, Vecchio D, Huang YY, Gupta A, Hamblin MR. 2013. Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond. Curr Opin Pharmacol 13:731-762. http://dx.doi.org/10.1016/j.coph.2013.08.009
23. Dai T, Gupta A, Huang YY, Yin R, Murray CK, Vrahas MS, Sherwood ME, Tegos GP, Hamblin MR. 2013. Blue light rescues mice from potentially fatal Pseudomonas aeruginosa burn infection: efficacy, safety, and mechanism of action. Antimicrob Agents Chemother 57:1238-1245. http://dx.doi.org/10.1128/AAC.01652-12
24. Dai T, Gupta A, Huang YY, Sherwood ME, Murray CK, Vrahas MS, Kielian T, Hamblin MR. 2013. Blue light eliminates communityacquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions. Photomed Laser Surg 31:531-538. http://dx.doi.org/10.1089/pho.2012.3365
25. Zhang Y, Zhu Y, Gupta A, Huang Y, Murray CK, Vrahas MS, Sherwood ME, Baer DG, Hamblin MR, Dai T. 2014. Antimicrobial blue light therapy for multidrug-resistant Acinetobacter baumannii infection in a mouse burn model: implications for prophylaxis and treatment of combat-related wound infections. J Infect Dis 209:1963-1971. http://dx.doi.org/10.1093/infdis/jit842
26. Bache SE, Maclean M, MacGregor SJ, Anderson JG, Gettinby G, Coia JE, Taggart I. 2012. Clinical studies of the high-intensity narrowspectrum light environmental decontamination system (HINS-light EDS), for continuous disinfection in the burn unit inpatient and outpatient settings. Burns 38:69-76. http://dx.doi.org/10.1016/j.burns.2011.03.008
27. Percival SL, Hill KE, Williams DW, Hooper SJ, Thomas DW, Costerton JW. 2012. A review of the scientific evidence for biofilms in wounds. Wound Repair Regen 20:647-657. http://dx.doi.org/10.1111/j.1524-475X.2012.00836.x
28. Percival SL, Kite P. 2007. Intravascular catheters and biofilm control. J Vasc Access 8:69-80
29. Burmølle M, Thomsen TR, Fazli M, Dige I, Christensen L, Homoe P, Tvede M, Nyvad B, Tolker-Nielsen T, Givskov M, Moser C, Kirketerp-Moller K, Johansen HK, Hoiby N, Jensen PO, Sorensen SJ, Bjarnsholt T. 2010.Biofilms in chronic infections-a matter of opportunity-monospecies biofilms in multispecies infections. FEMS Immunol Med Microbiol 59:324-336. http://dx.doi.org/10.1111/j.1574-695X.2010.00714.x
30. Høiby N, Bjarnsholt T, Moser C, Bassi GL, Coenye T, Donelli G, Hall-Stoodley L, Hola V, Imbert C, Lebeaux D, Oliver A, Ullmann AJ, Williams C. 2015. ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. Clin Microbiol Infect 21(Suppl 1):S1-S25. http://dx.doi.org/10.1016/j.cmi.2014.10.024
31. Halachev MR, Chan JZ, Constantinidou CI, Cumley N, Bradley C, Smith-Banks M, Oppenheim B, Pallen MJ. 2014. Genomic epidemiology of a protracted hospital outbreak caused by multidrug-resistant Acinetobacter baumannii in Birmingham, England. Genome Med 6(11):70. http://dx.doi.org/10.1186/s13073-014-0070-x
32. Villegas MV, Hartstein AI. 2003. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 24:284-295. http://dx.doi.org/10.1086/502205
33. Borer A, Gilad J, Smolyakov R, Eskira S, Peled N, Porat N, Hyam E, Trefler R, Riesenberg K, Schlaeffer F. 2005. Cell phones and Acinetobacter transmission. Emerg Infect Dis 11:1160-1161. http://dx.doi.org/10.3201/eid1107.050221
34. British Standards Institution. 2012. Chemical disinfectants and antiseptics-quantitative suspension test for the evaluation of bactericidal activity in the medical area-test methods and requirements (phase 2, step 1). Standards Publication BSI, BS EN13727. British Standards Institution, London, United Kingdom
35. Torok EME, Cooke F. 2009. Oxford handbook of infectious diseases and microbiology. Oxford University Press, Oxford, United Kingdom
36. Coohill TP, Sagripanti J-L. 2008. Overview of the inactivaton by 254 nm ultraviolet radiation of bacteria with particular reference to biodefence. Photochem Photobiol 84:1084-1090
37. Ceri H, Olson M, Morck D, Storey D, Read R, Buret A, Olson B. 2001. The MBEC assay system: multiple equivalent biofilms for antibiotic and biocide susceptibility testing. Methods Enzymol 337:377-385. http://dx.doi.org/10.1016/S0076-6879(01)37026-X
38. Liu GY, Nizet V. 2009. Color me bad: microbial pigments as virulence factors. Trends Microbiol 17:406-413. http://dx.doi.org/10.1016/j.tim.2009.06.006
39. Beard-Pegler MA, Stubbs E, Vickery AM. 1988. Observations on the resistance to drying of staphylococcal strains. J Med Microbiol 26:251-255. http://dx.doi.org/10.1099/00222615-26-4-251
40. Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian JF, Fierer J, Nizet V. 2005. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med 202:209-215. http://dx.doi.org/10.1084/jem.20050846
41. Clauditz A, Resch A, Wieland K-P, Peschel A, Götz F. 2006. Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect Immun 74:4950-4953. http://dx.doi.org/10.1128/IAI.00204-06
42. Guffey JS, Payne W, Jones T, Martin K. 2013. Evidence of resistance development by Staphylococcus aureus to an in vitro, multiple stage application of 405 m, light from a supraluminous diode array. Photomed Laser Surg 31:179-182. http://dx.doi.org/10.1089/pho.2012.3450
43. -2 on three species of bacteria in vitro. J Clin Laser Med Surg 20:325-333. http://dx.doi.org/10.1089/104454702320901116
44. Mussi MA, Gaddy JA, Cabruja M, Arivett BA, Viale AM, Rasia R, Actis LA. 2010. The opportunistic human pathogen Acinetobacter baumannii senses and responds to light. J Bacteriol 192:6336-6345. http://dx.doi.org/10.1128/JB.00917-10
45. Gaddy JA, Actis LA. 2009. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol 4:273-278. http://dx.doi.org/10.2217/fmb.09.5